PRAHIGH SIGNALRISK10-K

ProAssurance has entered into a definitive merger agreement to be acquired by The Doctors Company, fundamentally changing the company's trajectory as an independent entity.

The announced merger represents a complete strategic shift for shareholders, as PRA will cease to exist as a publicly traded company upon completion of the transaction. This development eliminates the company's independent growth prospects and transfers control to The Doctors Company, requiring shareholders to evaluate the merger terms rather than the company's standalone operational performance.

Comparing 2026-02-23 vs 2025-02-24View on EDGAR →
FINANCIAL ANALYSIS

The balance sheet shows mixed signals with stockholders' equity growing modestly to $1.3 billion while cash and equivalents declined notably to $36.5 million. The cash reduction may reflect operational pressures or transaction-related expenses, though the equity increase suggests underlying financial stability. Given the pending merger, these metrics primarily serve as baseline values for transaction evaluation rather than indicators of ongoing operational momentum.

FINANCIAL STATEMENT CHANGES
Cash & Equivalents
Balance Sheet
-33.5%
$54.9M→$36.5M

Cash declined 33.5% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Stockholders Equity
Balance Sheet
+12.3%
$1.2B→$1.3B

Equity base grew 12.3% — retained earnings accumulation or equity issuance strengthening the balance sheet.

LANGUAGE CHANGES
NEW — 2026-02-23
PRIOR — 2025-02-24
ADDED
As of February 18, 2026, the registrant had outstanding approximately 51,413,643 shares of its common stock.
Alternatively, such Part III information will be provided in an amendment to this Annual Report on Form 10-K, in either case to be filed within 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K.
Forward-looking statements are identified by words such as, but not limited to, "anticipate," "believe," "continue," "could," "estimate," "expect," "hope," "hopeful," "intend," "likely," "may," "optimistic," "plan," "possible," "potential," "preliminary," "project," "should," "will," "would" and other analogous expressions.
For the year ended December 31, 2025, our net premiums written totaled $0.9 billion, and at December 31, 2025 we had total assets of $5.4 billion and $1.3 billion of shareholders' equity.
Documents available on our website include the financial statements we file with state regulators (compiled under SAP as required by regulation), news releases that we issue and certain investor presentations.
+7 more — sign up free →
REMOVED
As of February 20, 2025, the registrant had outstanding approximately 51,156,821 shares of its common stock.
Forward-looking statements are identified by words such as, but not limited to, "anticipate," "believe," "estimate," "expect," "hope," "hopeful," "intend," "likely," "may," "optimistic," "possible," "potential," "preliminary," "project," "should," "will" and other analogous expressions.
For the year ended December 31, 2024, our net premiums written totaled $1.0 billion, and at December 31, 2024 we had total assets of $5.6 billion and $1.2 billion of shareholders' equity.
Documents available on our website include the financial statements we file with state regulators (compiled under SAP as required by regulation), news releases that we issue, a listing of our investment holdings and certain investor presentations.
See further discussion on our team members and culture within this section under the heading "Human Capital Resources." Provide specialized healthcare-centric expertise and thought leadership to meet the evolving demands in the healthcare and medical technology markets .
+7 more — sign up free →
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →